Skip to content

KLAVEX

Active Private limited companyfounded 2018active for 8 yearsKlaverheide 36, 2930 BrasschaatKBO/BCE: BE 0692.801.813

Lifetime

7 annual accounts with figures on one time axis
peak of €795,752 in 2024
€687,065▼ 13.7%
peak of €403,092 in 2024
€305,086▼ 24.3%
peak of €963,242 in 2024
€908,328▼ 5.7%
€719,830▼ 0.6%
Board2 names since 2008
1 director
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Gross margin from €795,752 to €687,065Dividend €360,000

Key points

from the 2025 annual accounts

Equity

€908,328 ▼ 5.7%
963,2422024+305,086Profit-360,000Dividend908,3282025

KLAVEX paid out €360,000 in dividends. That is 118% of the 2025 profit.

Filings

7 annual accounts since 2019
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 1 to 29 days before the end of the period.

Position in the sector

€305,086

Higher net result than 95% of companies in wholesale trade. The sector median is €5,117, over 15,511 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as KLAVEX has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for KLAVEX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-03-2008
  • 93 sharesdeed of 26-03-2018
  • 93 sharesdeed of 26-03-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0692801813
resigns as director Discharge granted to · General meeting of 09-01-2024 · Gazette deed
1 manager resigning, 2 directors reappointed resigns as director, formerly manager · (director) and (director) reappointed · General meeting of 25-01-2022 · Gazette deed
First establishment Mediplus Distribution, Klaverheide 36, Brasschaat
All 16 events

Comparable companies

same main activity, similar in size and age
Company
KLAVEX Brasschaat €1.6m €687,065 55.8% -
Farmadistri Oudenburg €1.6m €701,238 47.8% 2.1
FETON INTERNATIONAL La Louvière €1.4m €723,308 29.9% 6.2
MedXPress.Pro Leuven €1.5m €787,167 26.4% -
Herli Medical Kontich €2.0m €735,721 16.5% 13.2
OOGVOOROREN BELGIË Heist-op-den-Berg €1.2m €808,006 45.0% -
ADEPHAR Anzegem €1.1m €747,956 40.1% 4.6

These companies have the same main activity as KLAVEX: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.1m and €2m, founded between 2016 and 2019.

Official details

Source: KBO
Status
Active since 22-03-2018Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
Joint committee
207White-collar workers in the chemical industry · annual accounts 2025
Establishment unit
2.274.318.0222930 Brasschaat, since 26-03-2018
Financial year end
31 December
Peppol
Reachable since 04-09-2025
Company details

Annual accounts 2025

≈ €3.1mestimated
€1.6m▼ 3.5%
Employeeson 31-12-2025
3=
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on KLAVEX

KLAVEX files the micro format. That format states no turnover. The gross margin rose from €117,069 in 2019 to €687,065 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about KLAVEX

What is the company number of KLAVEX?
The company number of KLAVEX is 0692.801.813. The VAT number is the same number with BE in front: BE 0692.801.813.
Where is KLAVEX based?
The registered office is at Klaverheide 36, 2930 Brasschaat.Company details
What does KLAVEX do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of KLAVEX?
KLAVEX is a private limited company (BV).
When was KLAVEX founded?
KLAVEX was founded on 22-03-2018.
Is KLAVEX still active?
Yes, KLAVEX is an active enterprise in the KBO register.
How many employees does KLAVEX have?
KLAVEX had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does KLAVEX fall under?
In its 2025 annual accounts, KLAVEX states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of KLAVEX?
The turnover in financial year 2025 is about €3.1m. This figure is estimated from the gross margin of €687,065 and 40 comparable companies (NACE 464). It probably lies between €2.4m and €4.8m.
Is KLAVEX profitable?
In financial year 2025, KLAVEX made a profit of €305,086.
Where can I find the annual accounts of KLAVEX?
KLAVEX filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KLAVEX due?
KLAVEX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.